Alissa C O'Halloran1, Peng-Jun Lu2, Tamara Pilishvili3. 1. Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE, Mail Stop A 19, Atlanta, GA 30329, United States. Electronic address: idg3@cdc.gov. 2. Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE, Mail Stop A 19, Atlanta, GA 30329, United States. 3. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE, Mail Stop A 19, Atlanta, GA 30329, United States.
Abstract
BACKGROUND: Invasive pneumococcal disease is a major cause of illness in the United States, and rates are higher among persons ≥65 years. Pneumococcal vaccination has been recommended to adults ≥65 years since 1997. METHODS: Data from the 2005-2013 Behavioral Risk Factor Surveillance System were analyzed. Weighted estimates of pneumococcal vaccination coverage were calculated by state and race/ethnicity and tests for linear trend were performed. RESULTS: In 2013, the median state vaccination coverage among adults ≥65 years was 69.5%, and coverage ranged from 61.9% in New Jersey to 75.6% in Oregon. Coverage overall among non-Hispanic whites (71.1%) was higher than coverage for non-Hispanic blacks (57.7%), Hispanics (51.9%), and non-Hispanic persons of other race (65.4%). Coverage increased from 2005 to 2013 overall and by racial/ethnic subgroups. CONCLUSION: Although pneumococcal vaccination coverage has improved in the past several years, coverage remains below the Healthy People 2020 target of 90% and racial/ethnic disparities exist.
BACKGROUND: Invasive pneumococcal disease is a major cause of illness in the United States, and rates are higher among persons ≥65 years. Pneumococcal vaccination has been recommended to adults ≥65 years since 1997. METHODS: Data from the 2005-2013 Behavioral Risk Factor Surveillance System were analyzed. Weighted estimates of pneumococcal vaccination coverage were calculated by state and race/ethnicity and tests for linear trend were performed. RESULTS: In 2013, the median state vaccination coverage among adults ≥65 years was 69.5%, and coverage ranged from 61.9% in New Jersey to 75.6% in Oregon. Coverage overall among non-Hispanic whites (71.1%) was higher than coverage for non-Hispanic blacks (57.7%), Hispanics (51.9%), and non-Hispanic persons of other race (65.4%). Coverage increased from 2005 to 2013 overall and by racial/ethnic subgroups. CONCLUSION: Although pneumococcal vaccination coverage has improved in the past several years, coverage remains below the Healthy People 2020 target of 90% and racial/ethnic disparities exist.
Authors: Angel Vila-Corcoles; Olga Ochoa-Gondar; Imma Hospital; Cinta de Diego; Eva Satué; Jordi Bladé; Xabier Ansa; Jorge A Guzmán; Elisabet Salsench; Francisca Ramos Journal: Hum Vaccin Immunother Date: 2016-07-25 Impact factor: 3.452
Authors: Carla L Black; Walter W Williams; Rob Warnock; Tamara Pilishvili; David Kim; Jeffrey A Kelman Journal: MMWR Morb Mortal Wkly Rep Date: 2017-07-14 Impact factor: 17.586